Molbio Diagnostics Ltd

NSE: MOLBIO · BSE: 544866 · Healthcare · 8 announcements

Share price: ₹1,246.00
Market cap: ₹14,359 Cr
Revenue (annual): ₹1,446 Cr
Net profit (annual): ₹166.6 Cr
Promoter holding: 41.29%
FII holding: 1.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Results Update 1 Financial Results 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 13:34 IST BSE

Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics Limited re-appointed M/s. K.S. Kamalakara & Co as Cost Auditors for a 12-month term. The decision was finalized during a board meeting on September 25, 2026.

Execution: 12 months

Read the filing ↗

9 Sep 2026 12:12 IST NSE

Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics informed exchanges that its CIN changed from U33125GA2000PLC002909 to L33125GA2000PLC002909 post-listing. The MCA status was updated from Unlisted to Listed.

Read the filing ↗